Suchergebnisse - "Minassian, Angela M"

PubPharm (6)

1

Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK : eight-month analyses of the COV-BOOST trial

enthalten in: The Journal of infection | 2023

von Liu, X. | Munro, A. | Wright, A. | +59

2

Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK : Three month analyses of the COV-BOOST trial

enthalten in: The Journal of infection | 2022

von Liu, X. | Munro, A. | Feng, S. | +56

CommentIn: J Infect. 2023 Feb;86(2):154-225. - PMID 36509358

3

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 : a preliminary report of a phase 1/2, single-blind, randomised controlled trial

enthalten in: Lancet (London, England) | 2020

von Folegatti, P. | Ewer, K. | Aley, P. | +130

CommentIn: Lancet Infect Dis. 2020 Jul;20(7):760-761. - PMID 32325036

4

Safety and immunogenicity of an FP9-vectored candidate tuberculosis vaccine (FP85A), alone and with candidate vaccine MVA85A in BCG-vaccinated healthy adults : a phase I clinical trial

enthalten in: Human vaccines & immunotherapeutics | 2013

von Rowland, R. | Pathan, A. | Satti, I. | +16

5

Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults

enthalten in: Vaccine | 2012

von Pathan, A. | Minassian, A. | Sander, C. | +6

6

Th1/Th17 cell induction and corresponding reduction in ATP consumption following vaccination with the novel Mycobacterium tuberculosis vaccine MVA85A

enthalten in: PloS one | 2011

von Griffiths, K. | Pathan, A. | Minassian, A. | +5

1
[1]